706 results on '"Yeh, Yi-Chen"'
Search Results
2. Multifocal Papillary Thyroid Carcinomas With Discordant Molecular Drivers: Emphasizing the Morphology and Collision Tumors
3. The role of extensive lymph node dissection in the new grading system for lung adenocarcinoma
4. Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
5. Characteristics, treatment patterns, and clinical outcomes in patients with advanced non-small cell lung cancer harboring EGFR exon 20 insertions
6. Selenite selectively kills lung fibroblasts to treat bleomycin-induced pulmonary fibrosis
7. Effect of early dexamethasone on outcomes of COVID-19: A quasi-experimental study using propensity score matching
8. Dual-specificity phosphatases 22-deficient T cells contribute to the pathogenesis of ankylosing spondylitis
9. Clinical utility of immunohistochemical subtyping in patients with small cell lung cancer
10. Quantifying Interrater Agreement and Reliability Between Thoracic Pathologists: Paradoxical Behavior of Cohen’s Kappa in the Presence of a High Prevalence of the Histopathologic Feature in Lung Cancer
11. Comprehensive Genomic and Transcriptomic Analysis of Sclerosing Pneumocytoma
12. Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
13. Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract
14. The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma
15. A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis
16. Corrigendum
17. Treatment Patterns and Outcomes in Patients with Esophageal Cancer: An Analysis of a Multidisciplinary Tumor Board Database
18. NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression
19. TREM-1 enhances Mycobacterium tuberculosis-induced inflammatory responses in macrophages
20. Clinicopathological Significance of Pathologic Complete Lymph Node Regression After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
21. Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis
22. AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma
23. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis
24. Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology
25. Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?
26. Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung
27. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19
28. CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma
29. The Prognostic Impact of Extracapsular Lymph Node Involvement in Esophageal Squamous Cell Carcinoma
30. Lymphovascular Invasion as the Major Prognostic Factor in Node-Negative Esophageal Cancer After Primary Esophagectomy
31. Preoperative biopsy and tumor recurrence of stage I adenocarcinoma of the lung
32. Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signaling
33. Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis
34. ASO Visual Abstract: Treatment Patterns and Outcomes for Patients with Esophageal Cancer–An Analysis of a Multidisciplinary Tumor Board Database
35. The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
36. Comprehensive Genomic and Transcriptomic Analysis of Sclerosing Pneumocytoma
37. Toxicities, safeties and clinical response of dacarbazine-based chemotherapy on neuroendocrine tumors in Taiwan population
38. Ciliated Muconodular Papillary Tumors of the Lung
39. Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller
40. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center
41. Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery
42. Epidermal growth factor receptor mutations in non–smallcell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays
43. Epidermal growth factor receptor mutations in non–small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays
44. Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small ‐cell lung cancer patients with leptomeningeal metastases
45. Genomic Profiling With Large-Scale Next-Generation Sequencing Panels Distinguishes Separate Primary Lung Adenocarcinomas From Intrapulmonary Metastases
46. Elevated PD-L1 Expression and Microsatellite Instability in Elderly Patients With Gastric Cancer
47. Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas
48. Clinical, pathophysiologic, and genomic analysis of the outcomes of primary head and neck malignancy after pulmonary metastasectomy
49. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
50. Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.